Delhi orders 50% office attendance as toxic air triggers GRAP-3
Delhi’s worsening air pollution has pushed the city into GRAP-3, prompting the government and private offices to operate with only 50 percent staff on-site, while the rest work from home.
The directive, issued by the Commission for Air Quality Management (CAQM), comes as the capital battles yet another severe winter pollution spike.
Schools have already been instructed to limit outdoor activities, including halting children's play outside when air quality reaches the “very poor” zone.
Attendance in government offices was expected to be low anyway after Delhi declared a public holiday to mark the 350th Shaheedi Purab of Guru Tegh Bahadur.
Delhi relies on the graded GRAP system to decide how much restriction the city can absorb as pollution worsens each winter.
CAQM monitors the AQI across the entire NCR before activating each level.
On Saturday, the Delhi government again advised private offices to stick to the 50% in-person rule as GRAP-3 measures kicked in.
Environment Minister Manjinder Singh Sirsa said all GRAP-3 rules are being implemented “with full seriousness” and are being monitored around the clock.
IBNS
Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.
Related Articles
Delhi chokes as AQI slips to ‘severe’, smog blankets city
Delhi was shrouded in a thick haze on Sunday morning as air quality across the national capital slipped further into the ‘severe’ category.
Too much social media? Scientists find link to attention loss in kids
Children who spend significant time on social media may experience a gradual decline in their ability to concentrate, according to a comprehensive new study by Sweden’s Karolinska Institutet.
Traditional medicine takes center stage! WHO reveals a worldwide wellness boom!
The vast majority of World Health Organization (WHO) member States say 40 to 90 per cent of their populations now use traditional medicine.
Ozempic lands in India at just Rs 2,200 — The weight-loss shot arrives!
Drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, at a time when treatment demand for diabetes and weight loss is accelerating across the country.
Latest News
Goa nightclub fire horror: Luthra brothers brought back to India from Thailand, arrested
High-stakes Bangladesh elections: US Embassy sounds alarm for Americans
Messi chaos costs minister his job: Aroop Biswas resigns after Salt Lake Stadium fiasco
LG’s most advanced LCD ever: Micro RGB evo powered by OLED’s AI Brain
